Roger Pebody's profile photo

Roger Pebody

Paris

Medical Writer and Editor at Freelance

Medical journalist: aidsmap, The Lancet HIV, Medscape, TheBodyPro

Articles

  • 1 week ago | thelancet.com | Roger Pebody

    In a provincial Mexican city, a young gay man wakes up on a Saturday morning, recalls the events of the previous night and realises that he needs post-exposure prophylaxis (PEP). He's not sure if he can get it locally, especially with health services closed for the weekend, and he's worried about doctors judging him. As he only knows about PEP from Instagram posts by a group called VIHve Libre , he sends them a message.

  • 3 weeks ago | medscape.com | Roger Pebody

    An artificial intelligence (AI) model using routinely collected data predicted subsequent development of active tuberculosis (TB), Swiss researchers reported. The AI model outperformed biological tests for latent TB in identifying HIV-positive patients at high risk of developing TB. As well as immune function and sociodemographic variables, the AI model retained several biomarkers indicative of patients’ well-being and metabolism.

  • 2 months ago | aidsmap.com | Roger Pebody

    Estimated reading time 3 minutes While some countries have already shifted to less intensive monitoring requirements for PrEP users, a Dutch study has now provided evidence that it’s OK to test for sexually transmitted infections (STIs) every six months, to have clinic appointments at the same rhythm and for services to be delivered online. Simplified, less burdensome services had just as good outcomes as the standard of care.

  • Mar 5, 2025 | espanol.medscape.com | Roger Pebody

    Una calculadora de riesgo cardiovascular utilizada habitualmente por los profesionales médicos subestima el riesgo para las mujeres y las personas afrodescendientes que viven con infección por virus de inmunodeficiencia humana en los países de ingresos altos, mientras que sobreestima el riesgo para las personas con dicho virus en los países de ingresos bajos y medios.[1] Las puntuaciones de riesgo son un factor clave en las recomendaciones de las guías para la prescripción de estatinas y...

  • Feb 26, 2025 | medscape.com | Roger Pebody

    Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, research suggests. Currently, the intramuscular injections are provided by healthcare professionals. The new research might make self-injection of this antiretroviral therapy (ART) a more feasible option.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
1K
Tweets
2K
DMs Open
No
Roger Pebody
Roger Pebody @RogerPebody
18 Nov 24

RT @EATGx: We are glad to publish the reports from the #HIVGlasgow2024 Congress on our bulletin and website. ⤵️ Check out the website (tag…

Roger Pebody
Roger Pebody @RogerPebody
13 Aug 24

RT @NAT_AIDS_Trust: We are delighted that Manuel Guerrero, the British citizen living with HIV arrested in #Qatar, is finally free in Londo…

Roger Pebody
Roger Pebody @RogerPebody
25 Jul 24

RT @juliewreynolds1: Listen louder to this.